NMS
Neuromedin-S
Also known as: NMS_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5H8A3
- Gene
- NMS
- Ensembl
- ENSG00000204640
- Chromosome
- 2
- Canonical length
- 153 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted in brain
OverviewNCBI Gene
This gene encodes a member of the neuromedin family of neuropeptides. The encoded preproprotein is proteolytically processed to generate a biologically active neuropeptide that plays a role in the regulation of circadian rhythm, anorexigenic action, antidiuretic action, cardiovascular function and stimulation of oxytocin and vasopressin release. [provided by RefSeq, May 2016]
Canonical amino-acid sequenceUniProt
153 residues, UniProt reviewed canonical sequence.
>Q5H8A3|NMS
1 MKHLRPQFPL ILAIYCFCML QIPSSGFPQP LADPSDGLDI VQLEQLAYCL SQWAPLSRQP
61 KDNQDIYKRF LFHYSRTQEA THPVKTGFPP VHPLMHLAAK LANRRMKRIL QRGSGTAAVD
121 FTKKDHTATW GRPFFLFRPR NGRNIEDEAQ IQWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NMS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 1 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 1 nTPM
- spinal cord: 0.4 nTPM
- testis: 0.3 nTPM
- tongue: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
Single-cell type
- early spermatids: 2.2 nCPM
- other brain neurons: 1.6 nCPM
- foveolar cells: 1 nCPM
- neuroendocrine cells: 0.5 nCPM
- thyrotrophs: 0.3 nCPM
- b-cells: 0.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 5.7 nTPM
- spinal cord: 3.6 nTPM
- hypothalamus: 2 nTPM
- white matter: 1.5 nTPM
- thalamus: 1.1 nTPM
- pons: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.63
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.06
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 0% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Neuromedin U, amidation site
- Neuromedin S
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NMS as an antibody target. Whether an autoantibody or antibody against NMS could matter depends on whether native NMS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NMS is annotated as secreted, so native NMS circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label NMS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...